Time and cost of administering COVID-19 mRNA vaccines in the United States

In early 2020, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak a global pandemic. In response, two novel messenger RNA (mRNA)-based vaccines: mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) were rapidly developed. A thorough understanding of the diffe...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Benjamin Yarnoff, Steven Bodhaine, Ed Cohen, Philip O. Buck
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-11-01
Subjects:	covid-19 labor cost health economics mrna vaccine administration time usa
Online Access:	http://dx.doi.org/10.1080/21645515.2021.1974289